November 19 - 23, 2024
Vancouver, British Columbia
Visit Asuragen, a Bio-Techne brand at Booth #811 and join us at these sessions to learn how our products & services can empower you to provide better answers.
Visit Our BoothFireside Chat: LDT Compliance in an Uncertain Environment
With so much uncertainty around the FDA’s LDT Rule, it is challenging for laboratory leaders to make firm plans for how to achieve compliance. This session will consider three different tactical approaches for stage I of the rule: a) labs actively preparing for compliance; b) labs preparing, but cautiously using resources; and c) labs that are deferring preparation. No matter where your lab is on the spectrum, please join this interactive session as we discuss aspects of each approach and the practicalities of adjusting to the new regulatory landscape.
Wednesday, November 20
5:15 – 6:15 PM PST
Room 211
Discussion Leader:
Jordan Laser, MD
Senior Director, Clinical & Medical Affairs
Bio-Techne
In this workshop, we will showcase the design and performance of the QuantideX® qPCR ESR1 exoMutation Kit combined with the ExoLution Plus cfDNA/exosomal RNA Isolation Kit to deliver sensitivity of ≤0.1% for 11 ESR1 mutations located in the ligand-binding domain, utilizing the power of cfDNA and exosomal RNA isolated from exosomes to deliver best in class performance.
Brian Haynes, PhD
Chief Scientific Officer
Bio-Techne Diagnostics Division
In this workshop, Dr. Wadsworth of Stanford University will discuss the design and performance of the AmplideX® Carrier Plus Kit, combining Amplidex chemistry with the Oxford Nanopore® platform to identify the most challenging genetic alterations like CNVs, large inversions, and pseudogenes using a consolidated workflow.
Paul A. Wadsworth, MD, PhD
Resident Physician, Pathology
Stanford University
Learn how sequencing solutions from Oxford Nanopore Technologies are transforming molecular pathology. Hear about the latest developments in nanopore sequencing which provide a comprehensive view of both conventionally sequenced single nucleotide variants and small indels, and the detection of structural, repetitive, copy number, and methylation variants ― all in a single sequencing run. With its ability to read any length of DNA or RNA, from short to ultra-long, come and learn how nanopore technology empowers you to answer the bigger and bolder research questions you have always wanted to ask.
Anne-Sophie Lebre
Professor of Human Genetics & Clinical Molecular Geneticist,
Reims Medical School & University Hospital
Asuragen is excited to provide free headshot opportunities to all AMP attendees.
AmplideX® Nanopore Carrier Plus Kit*†
Streamlining carrier screening insights, even for the most challenging genes.
Asuragen will leverage its gold-standard PCR technology with Oxford Nanopore’s long-read DNA sequencing capabilities to develop the first sequencing system to identify the most challenging yet high prevalence carrier genes in a single, unified workstream that today requires multiple other methods.
Learn More about the AmplideX Nanopore Carrier Plus Kit
QuantideX® qPCR ESR1 exoMutation Kit*† + ExoLution™ Plus cfDNA + exoRNA Isolation Kit*†
The QuantideX qPCR ESR1 exoMutation Kit is paired with the ExoLution Plus cfDNA + exoRNA Isolation Kit, leveraging proprietary chemistries to co-isolate cfDNA + exoRNA in a single workflow. ExoLution Plus includes all necessary reagents and consumables for high-quality, multi-analyte isolation to power downstream mutation testing.
Visit our posters to view new data reinforcing our commitment to more equitable carrier screening research, comprehensive genetic coverage, and novel approaches to cancer monitoring & management.
G095
Blaine Caughron – Scientist, Asuragen
Saturday, November 23, 9:15am – 10:15am
G094
Connor A. Parker – Scientist, Asuragen
Friday, November 22, 9:15am – 10:15am
ID046
Deepa Eveleigh - Director, Production Custom & Lab Operations, Asuragen
Friday, November 22, 9:15am – 10:15am
G013
Anne-Sophie Lebre – Professor of Human Genetics & Clinical Molecular Geneticist, Reims Medical School & University
Saturday, November 23, 9:15am – 10:15am
*For Research Use Only. Not for use in diagnostic procedures. †This product is under development; performance characteristics and final product features to be determined. Trademarks and registered trademarks are the property of their respective owners.
Wednesday, November 20, 2024
Time: 7:00pm – 9:30pm
Venue: The Kent Vancouver
534 Cambie Street
Vancouver, BC
V6B 2N7